CLEC10A and neoplasm: MGL levels are increased on tumor-associated DCs and Mφs, as well as on tolerogenic DCs (5, 12, 14), which are able to dampen T cell immunity in a MGL-dependent manner through the interaction with Tn antigen on CD45 molecules of activated effector T cells.